{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-043363","form_type":"8-K","ticker":"CTOR","cik":"0001851484","company_name":"CITIUS ONCOLOGY, INC.","filed_at":"2025-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.153335+00:00","generated_at":"2026-05-21T10:22:52.912049+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Citius Oncology Q2 net loss widens to $7.7M; cash only $112, needs funding beyond May 2025","bullets":["Net loss of $7.7M ($0.11 per share) vs $4.8M loss a year ago; R&D and G&A expenses increased due to launch activities.","Cash and equivalents at March 31, 2025 totaled just $112; company requires additional capital to sustain operations beyond May 2025.","Retained Jefferies LLC as exclusive financial advisor to evaluate strategic alternatives aimed at maximizing stockholder value.","Advancing commercial launch of LYMPHIR (cutaneous T-cell lymphoma) after FDA approval; discussions with partners ongoing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-043363","json":"https://secwatch.observer/filing/0001213900-25-043363.json","markdown":"https://secwatch.observer/filing/0001213900-25-043363.md","text":"https://secwatch.observer/filing/0001213900-25-043363.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025043363/0001213900-25-043363-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025043363/ea0241972-8k_citius.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T10:22:52.912049+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}